A Trial of Tisotumab Vedotin in Cervical Cancer

Clinical trial NCT03438396 · COMPLETED

Trial details

NCT number: NCT03438396
Sponsor: Seagen Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer

Start date: 2018-06-12
Primary completion: 2020-02-06
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.